Collaboration
Lt Col Dr. Michal Kroča
Military Medical Agency, Military Health Institute, Biological Defence Department at Těchonín
Antitoxin therapyDr. Petr Jansa, Dr. Tomáš Cihlář, Dr. Richard Mackman
Gilead Sciences, Inc., Foster City, California, U.S.A.Biological activity screening, pharmacokinetic profiles of active compounds and mutual general cooperation within Gilead Sciences & IOCB Research Centre
Prof. Erik De Clercq, Prof. Jan Balzarini, Prof. Johan Neyts, Dr. Robert Snoeck, Dr. Lieve Naesens, Dr. Graciela Andrei
Rega Institute for Medical Research, Katholieke Universiteit Leuven, BelgiumAntiviral screening
Dr. Luke Guddat
The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, AustraliaAntimalarial program.
Dr. Nicholas P. West
The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia
Tuberculosis Research
Mjr Michael D. Edstein
Australian Defence Force Malaria and Infectious Disease Institute, Enoggera, Brisbane, Queensland, Australia
Antimalarial program
Dr. Zdeněk Zídek
Institute of Experimental Medicine, Academy of Sciences of the Czech RepublicImmunomodulatory activity
Dr. Helena Mertlíková-Kaiserová
IOCB Prague
Cytostatic activity, inhibitory activity towards thymidine phosphorylase.
Dr. Martin Dračínský
IOCB Prague
NMR spectroscopy
Dr. Alena Panicucci Zíková
Laboratory of Functional Biology of Protists, Institute of Parasitology, Biology Centre of the CAS